 |
|
|
Scientific Program
NEW!! The detailed program of the conference can now be downloaded.
The major subjects of the conference include:
Structural and functional models of metalloenzymes
Inhibition of metalloenzymes
Metal ion interactions with biomolecules (DNA, peptides, etc.)
Chelation therapy: Design and synthesis of selective chelating agents
Metal based drugs
Metal complexes as anticancer and antiviral agents
Metal complexes in the clinical diagnosis
Human diseases related to metal ion excess and/or deficiency
Metal ions and neurodegeneration
Bioorganometallic chemistry
Metal ion toxicology
Environmental aspects of bioinorganic chemistry, phytomining and phytoremediation
Analytical sensors based upon metal ions and/or ligands
Forms of presentations:
plenary lectures (invited)
session lectures (invited)
oral presentations (selected from Abstracts submitted before April 30, 2009)
posters
Plenary lectures (45 minutes)
| Speaker | Institute | tentative title |
| Silvio Aime | University of Torino, Italy | Metal Based Probes for Molecular Imaging Investigations |
| Roger Alberto | University of Zurich, Switzerland | Organometallic Complexes of the Mn-triad in Molecular Imaging and Therapy |
| Sue Berners-Price | University of Western Australia, Perth, Australia | Gold-Based, Mitochondria-Targeted Chemotherapeutics |
| Glenn Millhauser | University of California, Santa Cruz, US | Why we all have the mad cow prion protein: Insights into PrP`s function as a metalloprotein |
| Chris Orvig | University of British Columbia, Vancouver, Canada | Insulin-enhancing Vanadium Drugs: From Lunch Table Scribble to Clinical Trials |
| Vincent L. Pecoraro | University of Michigan, Ann Arbor, US | title will be announced later |
| Jan Reedijk | Leiden University, Netherlands | Platinum anticancer coordination compounds: Study of DNA binding inspires new drug design |
| Carel Wreesmann | AkzoNobel Chemicals, Arnhem, Netherland | Ferric Sodium EDTA for Therapeutic Uses |
Session lectures (25+5 minutes)
| Speaker | Town/Country | tentative title |
| Wojtiech Bal | Warsaw, PL | Nickel(II)-Related Peptide Bond Hydrolysis |
| Seth M. Cohen | San Diego, US | Fragment Based Approaches to Metalloprotein Inhibitors |
| Peter Comba | Heidelberg, DE | CO2 fixation by Copper Complexes of Cyclic Peptides |
| Robert Crichton | Louvain, BE | title will be announced later |
| Jose M. Dominguez-Vera | Granada, SP | Native and Synthetic Ferritins. Nanobiomedical Applications |
| Zijian Guo | Nanjing, China | The in vitro and in vivo applications of novel zinc fluorescent sensors |
| Róbert Gyurcsányi | Budapest, HU | Nanostructures and Synthetic Ligands Assisted (Bio)sensing |
| Béla Gyurcsik | Szeged, HU | Artificial Metallonucleases for Gene Therapy |
| Liang-nian Ji | Guangzhou, China | Sequence-dependent B/Z DNA conformational switching with Ru(II) polypyridyl complexes |
| Henryk Kozlowski | Wroclaw, PL | The Specific Interactions of Fish Prion Proteins with Metal Ions |
| Bernhard Lippert | Dortmund, DE | Metal Catalysis in Nucleic Acid Chemistry |
| Franc Meyer | Göttingen, DE | Oxidation and Oxygenation Chemistry with Bioinspired Dicopper and Diiron Complexes |
| Mikio Nakamura | Tokyo, JP | Regulation of Heme Electronic Structure by Means of Axial Ligands |
| Kevin B. Nolan | Dublin, IE | Hydroxamate Inhibitors of the Peroxidase and Cyclooxygenase Sites of Prostaglandin-H-Synthase |
| Giuseppe Pappalardo | Catania, IT | Copper(II) and Zinc(II) Interactions with the Amyloid beta Peptide: Structure of the Complexes, Oligomerisation and in vitro Toxicity |
| Peter Sadler | Warwick, UK | Photoactivated Metal Anticancer Complexes |
| Thanos Salifoglou | Thessaloniki, GR | title will be announced later |
| Roland K.O. Sigel | Zurich, CH | Controling Folding of Large RNAs by Divalent Metal Ions |
| Éva Tóth-Jakab | Orleans, FR | New Developments in Molecular Magnetic Resonance Imaging Agents and Bimodal Probes |
|
|
|